Teva forks over $150M to settle Texas opioid suit

After a high-profile trial loss in December, Teva Pharmaceuticals has reached a deal to put another major opioid lawsuit to bed.

Teva has agreed to pay Texas $150 million to settle claims that it helped fuel the state’s opioid epidemic. Under the agreement, struck with the Attorney General of Texas, Teva will pay the sum over 15 years. The generics giant will also provide supplies of the opioid overdose reversal drug Narcan.